ABT ABBOTT LABORATORIES
2026Q2 · CUSIP 002824100 · Sector: Healthcare & Biotech
Fund flows are within the usual range
2,992 funds held ABT at the end of 2026Q2, down 126 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $45.1B(YoY +6.6%), the P/E is 29.4x, return on equity is 12.1%. ABT has had 30 buying rushes in its history, and the price moved +8.4% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.
How many funds owned it, quarter by quarter
Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.
What happened after each past buying rush 30 times in its history
| Quarter of the rush | How unusual then | Price, next 3 months | Price, next 6 months |
|---|---|---|---|
| 2025Q4 | Top 5% | -20.7% | +3.1% |
| 2025Q1 | Top 1% in the market | -2.7% | -3.2% |
| 2024Q4 | Top 5% | +3.7% | +0.7% |
| 2024Q3 | Top 10% | +15.6% | +13.2% |
| 2024Q1 | Top 20% | +8.1% | +12.5% |
| 2023Q4 | Top 1% in the market | -8.2% | -0.8% |
| 2023Q2 | Top 10% | -6.6% | +9.8% |
| 2022Q4 | Top 1% in the market | +2.8% | -1.3% |
These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.
Show all the numbers (large funds, value held, options…) ▾ Collapse ▴
These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.
Fundamentals
Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable
P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden
FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden
As of 2026-03-31 · SEC filings (XBRL)
Email me the next update
2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.